| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4219125 | Academic Radiology | 2012 | 9 Pages |
Abstract
Baseline WB metabolic tumor burden, as measured with MTV and TLG, is a prognostic measurement in patients within Stage IV NSCLC with low interobserver variability. This study also suggests pretreatment MTV and TLG measurements may be used to further stratify patients with Stage IV NSCLC and are better prognostic measures than SUVmax and SUVmean measurements.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Shengri MD, Bill C. PhD, Hao MD, PhD, Kenji PhD, Yonglin MD, PhD,